PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |chronic kidney disease |
| Sentences | 122 |
| PubMedID- 26466319 | P-cresyl sulfate (pcs) is a risk factor of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 23338722 | chronic kidney disease (ckd) is associated with accelerated cardiovascular disease (cvd) risk and a higher cvd event rate. |
| PubMedID- 19812502 | The presence of chronic kidney disease was associated with total cardiovascular diseases, independently of frs (odds ratio 1.64, 95% confidence interval 1.33-2.02, p < 0.001), score (odds ratio 1.55, 95% confidence interval 1.21-1.98, p < 0.001) and progetto cuore rs (odds ratio 1.59, 95% confidence interval 1.22-2.07, p < 0.001). |
| PubMedID- 22445470 | Background: endothelial dysfunction (ed) is a key event in the development of atherosclerotic cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 24795256 | These bone-derived humoral factors might place the bone at the centre of cardiovascular disease associated with chronic kidney disease. |
| PubMedID- 24434383 | Knowledge of the epidemiology and risk profile of peripheral vascular disease among patients with chronic kidney disease (ckd) has a potential role for determining its outcome. |
| PubMedID- 20113258 | The importance of cardiovascular disease in adults with chronic kidney disease is now well recognized. |
| PubMedID- 24912660 | Conclusions: in patients with chronic kidney disease, intestinal uptake of p-cresol associates with cardiovascular disease independent of renal function. |
| PubMedID- 24489988 | Systemic inflammation and oxidative stress are nontraditional risk factors that are associated with premature cardiovascular disease commonly observed in patients with chronic kidney disease (ckd) [1, 2]. |
| PubMedID- 20430946 | It is not known if p-cresol is associated with cardiovascular disease in patients with chronic kidney disease not yet on dialysis. |
| PubMedID- 20979761 | [calcium and phosphorus metabolism and cardiovascular disease in chronic kidney disease]. |
| PubMedID- 24018401 | Traditional risk factors do not account for increased cardiovascular disease in patients with chronic kidney disease (ckd), particularly individuals whose ckd has progressed to end-stage kidney disease requiring dialysis. |
| PubMedID- 20401476 | When does the cardiovascular disease appear in patients with chronic kidney disease. |
| PubMedID- 24813858 | Vascular calcifications are a hallmark of advanced cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 20347511 | Background: vascular calcification contributes to cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 22516527 | Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the chronic renal insufficiency cohort [cric] study). |
| PubMedID- 23146975 | Assessment of peripheral vascular disease in patients with chronic kidney disease. |
| PubMedID- 23577141 | The cardiovascular disease burden in patients with chronic kidney disease (ckd) is substantial and derives from numerous aggregating cardiovascular risk factors [1]. |
| PubMedID- 25499229 | Vitamin d receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease. |
| PubMedID- 26409637 | Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the chronic renal insufficiency cohort study). |
| PubMedID- 23095239 | Cardiovascular disease is increased in patients with chronic kidney disease (ckd) and is the principle cause of morbidity and mortality in these patients. |
| PubMedID- 24867675 | Purpose of review: high levels of fibroblast growth factor 23 (fgf23) cause the rare disorders of hypophosphatemic rickets and are a risk factor for cardiovascular disease and death in patients with chronic kidney disease (ckd). |
| PubMedID- 24924917 | Cardiovascular disease is often associated with chronic kidney disease and vice versa; myocardial vitamin d receptors (vdrs) are among the probable links between the 2 disorders. |
| PubMedID- 26102877 | Objective: increased risk of cardiovascular disease in patients with chronic kidney disease (ckd) has been related to vascular stiffness and isolated systolic hypertension as a result of vascular calcification due to mineral metabolism abnormalities. |
| PubMedID- 24966085 | Reduced nitric oxide (no) synthesis contributes to risk for cardiovascular disease in chronic kidney disease (ckd). |
| PubMedID- 21595847 | Vascular calcification is the most important cause of cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 22127399 | A plethora of evidence has indicated that strict bp reduction is indispensable to improve patients’ prognosis, inadequate control of bp is thus leaving patients at risk of cardiovascular disease, particularly in patients with chronic kidney disease (ckd) and uncontrollable hypertension [1]. |
| PubMedID- 23740131 | Background: hyperphosphatemia is associated with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 25612295 | Background: chronic kidney disease (ckd) is associated with accelerated cardiovascular disease and heart failure. |
| PubMedID- 23573421 | Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 24819675 | Elevated serum phosphorus levels are common in patients with chronic kidney disease and are associated with heart and vascular disease, conditions that in turn are associated with increased mortality. |
| PubMedID- 21465119 | Role of chronic kidney disease in cardiovascular disease: are we different from others. |
| PubMedID- 23927055 | Cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21415179 | This article should help readers select the most appropriate unenhanced mr angiographic technique to assess vascular diseases in patients with chronic kidney disease. |
| PubMedID- 21251296 | Schematic depiction of the pathological process of tubular degeneration and tubulointerstitial fibrosis characteristic of tubulointerstitial diseases, and also of later stages of glomerular and renovascular diseases leading to chronic kidney disease (adapted from references [87]and [291]). |
| PubMedID- 24855061 | Coronary artery calcification (cac) is a prevalent form of cardiovascular disease in chronic kidney disease. |
| PubMedID- 23769135 | Increases in serum concentrations of parathyroid hormone (pth) and fibroblast growth factor 23 (fgf-23) and ultimately phosphate and decreases in 1,25-dihydroxyvitamin d level are thought to play a central role in the progressive nature of kidney disease and the development of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 24137013 | It was discovered during the search to identify proteins secreted by the kidney that could help explain the high incidence of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 26215643 | Serum phosphorus level is a risk factor for cardiovascular disease in patients with chronic kidney disease (ckd) [1–3]. |
| PubMedID- 22410492 | Chronic microinflammation and its cellular hallmark, monocyte activation, contribute substantially to the tremendous burden of cardiovascular disease (cvd) in patients with chronic kidney diseases (ckd). |
| PubMedID- 21105458 | [obesity--the risk factor of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 26429402 | In this review, i argue that despite differences in the pathophysiology and clinical features of cardiovascular disease in patients with and without chronic kidney disease, mr antagonists could provide cardiovascular benefit in patients with chronic kidney disease. |
| PubMedID- 23419899 | The burden of cardiovascular disease is high in patients with chronic kidney disease or end-stage renal disease. |
| PubMedID- 24084210 | Reduced nitric oxide bioavailability contributes to increased cardiovascular disease risk in patients with chronic kidney disease (ckd). |
| PubMedID- 25338421 | Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention. |
| PubMedID- 22916063 | Given the large burden of cardiovascular disease in individuals with chronic kidney disease, assessing the relationship between estimated grr (egfr) and vascular stiffness parameters in its early stage is important. |
| PubMedID- 21784369 | Assessment and management of vascular disease risk in patients with chronic kidney disease. |
| PubMedID- 24650765 | Increased numbers of the population predict the risk of cardiovascular disease in patients with chronic kidney disease [40], patients receiving hemodialysis [41], and patients selected for coronary angiography [42]. |
| PubMedID- 22719023 | Aims: high calcium (ca), phosphate (p), and ca-p product (cpp) are associated with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21406649 | Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. |